NIH Drug Repurposing Program Produces Surprise Overlaps
Crowdsourcing among researchers produces several applications proposing to test a few compounds in the NCATS repurposing library for use in multiple new indications, which officials did not expect.
You may also be interested in...
When NCATS was created, industry was wary of allowing Phase III trials; now sponsors embrace it.
Some advocates and researchers say that data availability could inform repurposing opportunities for products, but a GSK exec cautions that it could just as easily bring a flood of confusing information.
With its first set of grants funded, NCATS wonders whether it should try to solicit repurposing candidates that are still being worked on, rather than only using those that have been shelved.